Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS ...

FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek ® Guava ® Muse ...

Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable.

Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has developed a revolutionary tool to automate panel design. The company has expanded the capabilities of the Panel Builder tool ...

About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution ...

Piper Sandler analyst David Westenberg maintained a Buy rating on Cytek Biosciences (CTKB – Research Report) today and set a price target of ...

Cytek Biosciences, Inc. has a 1-year low of $3.27 and a 1-year high of $7.63. The firm has a market capitalization of $467.55 million, a PE ratio of -45.62 and a beta of 1.41.

Ph.D., CTO of Cytek Biosciences. “Traditional flow cytometry systems can be cost-prohibitive and workflow-intensive, limiting their use to only the most well-funded, deeply-staffed labs. By leveraging ...

FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek ® Guava ® Muse ...